Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation
The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK)...
        Saved in:
      
    
          | Published in | Autophagy Vol. 17; no. 2; pp. 529 - 552 | 
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        United States
          Taylor & Francis
    
        01.02.2021
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1554-8627 1554-8635 1554-8635  | 
| DOI | 10.1080/15548627.2020.1725381 | 
Cover
| Abstract | The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14
+/+
-Atg5
f/f
KCs and Krt14
Cre/+
-atg5
f/f
KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14
Cre/+
-atg5
f/f
KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14
Cre/+
-hmgb1
f/f
mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis.
Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A
1
; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14
+/+
-Atg5
f/f
mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14
+/+
-Hmgb1
f/f
: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14
Cre/+
-atg5
f/f
mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14
Cre/+
-hmgb1
f/f
mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells. | 
    
|---|---|
| AbstractList | The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between
KCs and
KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in
KCs
. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that
mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis.
3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A
; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum;
shRNA: lentivirus harboring shRNA against
; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1;
shRNA: lentivirus harboring shRNA against
; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout;
mice: mice bearing an
allele, in which exon 3 of the
gene is flanked by two loxP sites;
: mice bearing an
flox allele, in which exon 2 to 4 of the
gene is flanked by two loxP sites;
mice: keratinocyte-specific
knockout mice generated by mating
mice with mice expressing
recombinase under the control of the promoter of
mice: keratinocyte-specific
knockout mice generated by mating
mice with mice expressing
recombinase under the control of the promoter of
mice: mice expressing 164-amino acid
splice variant recombinase under the control of promoter of
; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor;
KO mice:
(T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells. The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14+/+-Atg5f/f KCs and Krt14Cre/+-atg5f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14Cre/+-atg5f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14Cre/+-hmgb1f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis.Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A1; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14+/+-Atg5f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14+/+-Hmgb1f/f: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14Cre/+-atg5f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14Cre/+-hmgb1f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14+/+-Atg5f/f KCs and Krt14Cre/+-atg5f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14Cre/+-atg5f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14Cre/+-hmgb1f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis.Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A1; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14+/+-Atg5f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14+/+-Hmgb1f/f: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14Cre/+-atg5f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14Cre/+-hmgb1f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells. The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14+/+-Atg5f/f KCs and Krt14Cre/+-atg5f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14Cre/+-atg5f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14Cre/+-hmgb1f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis. Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A1; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco’s modified Eagle’s medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14+/+-Atg5f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14+/+-Hmgb1f/f: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14Cre/+-atg5f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14Cre/+-hmgb1f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells. The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14 +/+ -Atg5 f/f KCs and Krt14 Cre/+ -atg5 f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14 Cre/+ -atg5 f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14 Cre/+ -hmgb1 f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis. Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A 1 ; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14 +/+ -Atg5 f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14 +/+ -Hmgb1 f/f : mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14 Cre/+ -atg5 f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14 Cre/+ -hmgb1 f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.  | 
    
| Author | Cui, Kaijun Zou, Song Wang, Zhen Li, Wei Cheng, Juan Liu, Xiao Wu, Wenling Zhao, Qixiang Shen, Guobo Huang, Nongyu Hu, Yawen Zhou, Xikun Hu, Zhonglan Li, Jiong Zhang, Chen Hao, Yan Zhou, Yifan Gui, Yiyue Hu, Jing Teng, Xiu Zheng, Huaping Chen, Shuwen Wei, Yuquan Zhou, Hong Wang, Xiaoyan Zhang, Jun Wei, Xiaoqiong Zeng, Fanlian  | 
    
| Author_xml | – sequence: 1 givenname: Zhen surname: Wang fullname: Wang, Zhen organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 2 givenname: Hong surname: Zhou fullname: Zhou, Hong organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 3 givenname: Huaping surname: Zheng fullname: Zheng, Huaping organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 4 givenname: Xikun orcidid: 0000-0001-6768-2382 surname: Zhou fullname: Zhou, Xikun organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 5 givenname: Guobo surname: Shen fullname: Shen, Guobo organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 6 givenname: Xiu surname: Teng fullname: Teng, Xiu organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 7 givenname: Xiao surname: Liu fullname: Liu, Xiao organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 8 givenname: Jun surname: Zhang fullname: Zhang, Jun organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 9 givenname: Xiaoqiong orcidid: 0000-0001-7576-4820 surname: Wei fullname: Wei, Xiaoqiong organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 10 givenname: Zhonglan surname: Hu fullname: Hu, Zhonglan organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 11 givenname: Fanlian surname: Zeng fullname: Zeng, Fanlian organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 12 givenname: Yawen surname: Hu fullname: Hu, Yawen organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 13 givenname: Jing surname: Hu fullname: Hu, Jing organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 14 givenname: Xiaoyan surname: Wang fullname: Wang, Xiaoyan organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 15 givenname: Shuwen surname: Chen fullname: Chen, Shuwen organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 16 givenname: Juan surname: Cheng fullname: Cheng, Juan organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 17 givenname: Chen surname: Zhang fullname: Zhang, Chen organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 18 givenname: Yiyue surname: Gui fullname: Gui, Yiyue organization: Sichuan University – sequence: 19 givenname: Song orcidid: 0000-0002-7219-3425 surname: Zou fullname: Zou, Song organization: Sichuan University – sequence: 20 givenname: Yan surname: Hao fullname: Hao, Yan organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 21 givenname: Qixiang surname: Zhao fullname: Zhao, Qixiang organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 22 givenname: Wenling surname: Wu fullname: Wu, Wenling organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 23 givenname: Yifan surname: Zhou fullname: Zhou, Yifan organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 24 givenname: Kaijun surname: Cui fullname: Cui, Kaijun organization: Sichuan University – sequence: 25 givenname: Nongyu surname: Huang fullname: Huang, Nongyu organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 26 givenname: Yuquan surname: Wei fullname: Wei, Yuquan organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy – sequence: 27 givenname: Wei surname: Li fullname: Li, Wei organization: Sichuan University – sequence: 28 givenname: Jiong surname: Li fullname: Li, Jiong email: lijionghh@scu.edu.cn organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32019420$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNqNkctu1DAUhiNURC_wCCAv2aT4EjseISFKBS1SERtYWyeO05o6drCTGWXL8_BufYU6zLRcFsDKx8f_9x_792Gx54M3RfGU4GOCJX5BOK-koPUxxTS3asqZJA-Kg6VfSsH43n1N6_3iMKUvGDMhV_RRsc8oJquK4oNiczKNYbiCy7lsIJkWTV4HvzZ-tMGDQ8noaJYahQ6dfzh7Q1Azo2sTYbQ-6Hk0CQ0O5oQADXYdxszE4AyyHg0pRJt1GqXrvLX-5vs36HtY7B4XDztwyTzZrUfF53dvP52elxcfz96fnlyUmrNqLLnBrOOdllVHJW3pShjGsGyYbqHFIGupqWxEJTrRiJq2XFS8xoIbQbTJr2RHhdj6Tn6AeQPOqSHaHuKsCFZLkuouSbUkqXZJZvDVFhympjetzolE-AkHsOr3E2-v1GVYK4lxTcQy-fnOIIavk0mj6m3SxjnwJkxJUcYJJyvKRZY--3XW_ZC7b8oCvhXoGFKKpvvvR7z8g9N2_JF_vrJ1_6Rfb2nruxB72IToWjXC7ELsInhtk2J_t7gF4qfOBA | 
    
| CitedBy_id | crossref_primary_10_3390_ijms25020771 crossref_primary_10_1002_pmic_202300184 crossref_primary_10_1016_j_intimp_2023_110221 crossref_primary_10_1016_j_jprot_2024_105195 crossref_primary_10_1186_s12915_021_01058_5 crossref_primary_10_3390_biomedicines11041130 crossref_primary_10_1016_j_intimp_2024_112244 crossref_primary_10_1016_j_biopha_2023_114421 crossref_primary_10_1016_j_intimp_2023_111397 crossref_primary_10_3390_ijms25105387 crossref_primary_10_7717_peerj_11278 crossref_primary_10_1016_j_clim_2024_110308 crossref_primary_10_1016_j_canlet_2023_216494 crossref_primary_10_1038_s41419_023_06094_3 crossref_primary_10_1007_s00403_024_03219_2 crossref_primary_10_12677_HJBM_2022_123018 crossref_primary_10_1111_php_13863 crossref_primary_10_1038_s41420_022_01228_6 crossref_primary_10_1038_s41577_023_00894_6 crossref_primary_10_1038_s41419_021_04181_x crossref_primary_10_1080_15569527_2022_2127750 crossref_primary_10_3389_fmed_2024_1335551 crossref_primary_10_1038_s41392_022_01219_0 crossref_primary_10_1038_s41392_023_01655_6 crossref_primary_10_3389_fimmu_2021_714274 crossref_primary_10_1080_00207454_2024_2352781 crossref_primary_10_1111_exd_14909 crossref_primary_10_1186_s12964_024_01758_9 crossref_primary_10_2147_CCID_S476785 crossref_primary_10_1016_j_jbc_2024_105677 crossref_primary_10_3390_biom11091334 crossref_primary_10_3390_ani13010092 crossref_primary_10_1002_advs_202205462 crossref_primary_10_1111_jocd_15282 crossref_primary_10_3390_biom12010060 crossref_primary_10_1039_D2BM01586B crossref_primary_10_1111_exd_15159 crossref_primary_10_1080_15548627_2021_2008692 crossref_primary_10_3892_or_2023_8653 crossref_primary_10_1016_j_canlet_2024_216621 crossref_primary_10_1111_bph_17349 crossref_primary_10_3389_fphar_2023_1092473 crossref_primary_10_1016_j_celrep_2024_114261 crossref_primary_10_1038_s41419_024_06583_z crossref_primary_10_1080_08820139_2023_2288836 crossref_primary_10_1172_JCI156501 crossref_primary_10_1016_j_intimp_2023_110915 crossref_primary_10_1016_j_phymed_2024_155917 crossref_primary_10_2478_aite_2024_0005 crossref_primary_10_3390_ijms25116068 crossref_primary_10_1038_s41419_024_06514_y crossref_primary_10_3389_fimmu_2024_1343987 crossref_primary_10_1021_acsomega_5c00336 crossref_primary_10_1038_s41419_022_05045_8 crossref_primary_10_1016_j_phymed_2023_155041 crossref_primary_10_1016_j_jdermsci_2022_07_005 crossref_primary_10_3390_cimb46040228 crossref_primary_10_2174_0113894501277656231128060242 crossref_primary_10_1007_s00018_024_05433_7 crossref_primary_10_1002_advs_202400107 crossref_primary_10_3389_fcell_2021_672847 crossref_primary_10_1038_s41419_022_04591_5 crossref_primary_10_1177_15330338241307686 crossref_primary_10_1186_s43556_024_00178_y crossref_primary_10_1186_s12967_024_04932_2 crossref_primary_10_1016_j_jid_2022_10_020 crossref_primary_10_1016_j_jid_2023_12_023 crossref_primary_10_1097_JD9_0000000000000353 crossref_primary_10_1111_bph_15983 crossref_primary_10_1002_cjoc_202300649 crossref_primary_10_1016_j_jnutbio_2025_109890 crossref_primary_10_2147_PTT_S327310 crossref_primary_10_3390_cells11152410 crossref_primary_10_1002_med_21884 crossref_primary_10_1038_s41419_022_04523_3 crossref_primary_10_1016_j_mce_2021_111417 crossref_primary_10_1186_s13578_024_01238_0 crossref_primary_10_1111_1346_8138_16874 crossref_primary_10_1681_ASN_0000000000000024 crossref_primary_10_3390_molecules27072361 crossref_primary_10_1016_j_intimp_2024_112704 crossref_primary_10_1016_j_ijbiomac_2022_12_299 crossref_primary_10_1016_j_jid_2021_05_016 crossref_primary_10_1016_j_tiv_2022_105378 crossref_primary_10_3389_fimmu_2024_1486627 crossref_primary_10_1039_D2FO02545K crossref_primary_10_2147_CCID_S284300 crossref_primary_10_3389_fcell_2022_892450 crossref_primary_10_5826_dpc_1403a177 crossref_primary_10_1097_JD9_0000000000000297 crossref_primary_10_2147_CCID_S422355 crossref_primary_10_3390_cells13201675 crossref_primary_10_1016_j_intimp_2024_113508 crossref_primary_10_1021_acsnano_4c13533 crossref_primary_10_3389_fphar_2022_844756 crossref_primary_10_3390_cells11223691 crossref_primary_10_1111_1346_8138_16185 crossref_primary_10_1016_j_intimp_2023_110331 crossref_primary_10_1371_journal_ppat_1012133 crossref_primary_10_1080_14728222_2024_2375373 crossref_primary_10_1155_2023_3397940 crossref_primary_10_1016_j_biopha_2023_115246 crossref_primary_10_1016_j_heliyon_2024_e29859 crossref_primary_10_3389_fmed_2023_1292722 crossref_primary_10_1080_10985549_2024_2325527 crossref_primary_10_1371_journal_pone_0314873 crossref_primary_10_1016_j_molimm_2023_09_004 crossref_primary_10_1016_j_biopha_2021_112297 crossref_primary_10_1002_lary_31416 crossref_primary_10_1002_iid3_1205 crossref_primary_10_1016_j_freeradbiomed_2024_08_004  | 
    
| Cites_doi | 10.1038/nature04724 10.1016/j.devcel.2018.03.023 10.1371/journal.pone.0135898 10.1016/j.canlet.2013.11.019 10.1016/j.jid.2019.02.021 10.1016/j.jid.2018.02.035 10.1016/j.chom.2017.10.008 10.1111/1346-8138.13695 10.1016/j.jaad.2004.04.012 10.1007/s40261-018-0656-y 10.1111/j.1440-1711.2006.01454.x 10.1080/15548627.2016.1159375 10.1242/jcs.176412 10.1038/nprot.2008.211 10.1146/annurev-immunol-032713-120225 10.1016/j.jid.2016.03.016 10.1016/j.molcel.2018.11.018 10.1038/ni.2215 10.1186/s13024-018-0273-5 10.1038/nri3532 10.1182/blood-2002-12-3793 10.4049/jimmunol.0902464 10.1016/j.mam.2014.05.001 10.1093/emboj/cdg516 10.1242/jcs.144816 10.1016/j.jid.2016.06.618 10.1007/s00403-014-1508-0 10.7150/thno.15584 10.1038/emboj.2011.398 10.18632/oncotarget.9330 10.4161/viru.2.2.15480 10.4049/jimmunol.1202495 10.1084/jem.20100559 10.1038/ncomms6779 10.1007/s00403-013-1330-0 10.1038/ni.3273 10.1007/s00430-010-0163-0 10.1016/j.immuni.2011.08.001 10.1038/ncomms8687 10.1038/cdd.2011.78 10.1038/ncb2979 10.1016/j.tcb.2012.04.008 10.1080/15548627.2017.1402992 10.1111/jdv.13564 10.1146/annurev-immunol-020711-074948 10.1172/JCI61862 10.1002/path.4848 10.1038/nprot.2009.241 10.1016/j.bbadis.2018.02.003 10.1080/15548627.2015.1100356 10.4049/jimmunol.0802999 10.4049/jimmunol.1001954 10.1111/j.1365-2133.1992.tb07805.x 10.18632/oncotarget.17885 10.1038/sj.cdd.4401984 10.15252/embj.201695081 10.1016/j.immuni.2009.08.001 10.1016/j.cyto.2011.08.022 10.1111/j.1346-8138.2011.01458.x 10.1016/S0140-6736(18)30485-9 10.4049/jimmunol.1300047 10.1016/j.bbrc.2014.11.038 10.1038/jid.2012.318 10.3389/fphys.2015.00093 10.1007/s00018-011-0702-x 10.3389/fimmu.2018.01512 10.1038/nri2622 10.1038/onc.2012.631 10.1016/j.molcel.2009.04.026 10.2340/00015555-1183 10.1038/nrrheum.2011.222 10.1016/j.bcp.2016.06.001 10.1038/emboj.2010.74 10.1083/jcb.200911078 10.1038/nprot.2008.50 10.4049/jimmunol.1303297 10.1146/annurev-immunol-030409-101323 10.1016/j.immuni.2012.04.008  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2020 Informa UK Limited, trading as Taylor & Francis Group 2020 2020 Informa UK Limited, trading as Taylor & Francis Group 2020 Informa UK Limited, trading as Taylor & Francis Group  | 
    
| Copyright_xml | – notice: 2020 Informa UK Limited, trading as Taylor & Francis Group 2020 – notice: 2020 Informa UK Limited, trading as Taylor & Francis Group 2020 Informa UK Limited, trading as Taylor & Francis Group  | 
    
| DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY  | 
    
| DOI | 10.1080/15548627.2020.1725381 | 
    
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic  | 
    
| DatabaseTitleList | PubMed MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Biology | 
    
| DocumentTitleAlternate | Z. WANG ET AL | 
    
| EISSN | 1554-8635 | 
    
| EndPage | 552 | 
    
| ExternalDocumentID | 10.1080/15548627.2020.1725381 PMC8007160 32019420 10_1080_15548627_2020_1725381 1725381  | 
    
| Genre | Research Article Research Support, Non-U.S. Gov't Journal Article  | 
    
| GroupedDBID | --- 0BK 0R~ 23N 30N 4.4 53G 5GY AAGDL AAHIA AAJMT AALDU AAMIU AAPUL AAQRR ABCCY ABFIM ABJNI ABLIJ ABPAQ ABPEM ABTAI ABXUL ABXYU ACGFS ACTIO ADBBV ADCVX ADGTB ADHGD AEISY AENEX AEYOC AFRVT AGDLA AHDZW AIJEM AIYEW AKBVH AKOOK ALMA_UNASSIGNED_HOLDINGS ALQZU AOIJS AQRUH AQTUD AVBZW AWYRJ BAWUL BLEHA CCCUG DGEBU DIK DKSSO E3Z EBS EMOBN F5P GTTXZ H13 HYE IPNFZ KYCEM LJTGL M4Z O9- OK1 P2P RIG RNANH ROSJB RPM RTWRZ SNACF TASJS TBQAZ TDBHL TEI TFL TFT TFW TQWBC TR2 TTHFI TUROJ ZGOLN AAYXX CITATION AAGME ABFMO ACDHJ ACZPZ ADOPC ADYSH AURDB BFWEY C1A CWRZV EJD NPM PCLFJ 7X8 5PM ACFTK ADTOC UNPAY  | 
    
| ID | FETCH-LOGICAL-c534t-5e03f5fc84f282d296e3308b3cdad0a878c28b646f6b672d56457065e61ce3203 | 
    
| IEDL.DBID | UNPAY | 
    
| ISSN | 1554-8627 1554-8635  | 
    
| IngestDate | Sun Oct 26 04:07:54 EDT 2025 Tue Sep 30 17:04:46 EDT 2025 Thu Oct 02 06:09:21 EDT 2025 Mon Jul 21 05:28:20 EDT 2025 Thu Apr 24 23:07:45 EDT 2025 Wed Oct 01 03:29:25 EDT 2025 Mon Oct 20 23:49:13 EDT 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 2 | 
    
| Keywords | Alarmin autophagy secretion keratinocytes psoriasis  | 
    
| Language | English | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c534t-5e03f5fc84f282d296e3308b3cdad0a878c28b646f6b672d56457065e61ce3203 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. Co-corresponding authors  | 
    
| ORCID | 0000-0001-7576-4820 0000-0001-6768-2382 0000-0002-7219-3425  | 
    
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.tandfonline.com/doi/pdf/10.1080/15548627.2020.1725381?needAccess=true | 
    
| PMID | 32019420 | 
    
| PQID | 2351519256 | 
    
| PQPubID | 23479 | 
    
| PageCount | 24 | 
    
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8007160 proquest_miscellaneous_2351519256 unpaywall_primary_10_1080_15548627_2020_1725381 informaworld_taylorfrancis_310_1080_15548627_2020_1725381 crossref_citationtrail_10_1080_15548627_2020_1725381 crossref_primary_10_1080_15548627_2020_1725381 pubmed_primary_32019420  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2021-02-01 | 
    
| PublicationDateYYYYMMDD | 2021-02-01 | 
    
| PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-01 day: 01  | 
    
| PublicationDecade | 2020 | 
    
| PublicationPlace | United States | 
    
| PublicationPlace_xml | – name: United States | 
    
| PublicationTitle | Autophagy | 
    
| PublicationTitleAlternate | Autophagy | 
    
| PublicationYear | 2021 | 
    
| Publisher | Taylor & Francis | 
    
| Publisher_xml | – name: Taylor & Francis | 
    
| References | cit0033 cit0077 cit0034 cit0078 cit0031 cit0075 cit0032 cit0076 cit0073 cit0030 cit0074 cit0071 cit0072 cit0070 cit0037 cit0038 cit0035 cit0079 cit0036 cit0022 cit0066 cit0023 cit0067 cit0020 cit0064 cit0021 cit0065 cit0062 cit0063 cit0060 cit0061 cit0028 cit0029 cit0026 cit0027 cit0024 cit0068 cit0025 cit0069 cit0011 cit0055 cit0012 cit0056 cit0053 cit0010 cit0054 cit0051 cit0052 cit0050 Zhang M (cit0039) 2015 cit0019 cit0017 cit0018 cit0015 cit0059 cit0016 cit0013 cit0057 cit0014 cit0058 cit0044 cit0001 cit0045 cit0042 cit0043 cit0040 cit0041 cit0008 cit0009 cit0006 cit0007 cit0004 cit0048 cit0005 cit0049 cit0002 cit0046 cit0003 cit0047  | 
    
| References_xml | – ident: cit0032 doi: 10.1038/nature04724 – ident: cit0040 doi: 10.1016/j.devcel.2018.03.023 – ident: cit0070 doi: 10.1371/journal.pone.0135898 – ident: cit0051 doi: 10.1016/j.canlet.2013.11.019 – ident: cit0053 doi: 10.1016/j.jid.2019.02.021 – ident: cit0056 doi: 10.1016/j.jid.2018.02.035 – ident: cit0077 doi: 10.1016/j.chom.2017.10.008 – ident: cit0073 doi: 10.1111/1346-8138.13695 – ident: cit0074 doi: 10.1016/j.jaad.2004.04.012 – ident: cit0010 doi: 10.1007/s40261-018-0656-y – ident: cit0030 doi: 10.1111/j.1440-1711.2006.01454.x – ident: cit0038 doi: 10.1080/15548627.2016.1159375 – ident: cit0062 doi: 10.1242/jcs.176412 – ident: cit0036 doi: 10.1038/nprot.2008.211 – ident: cit0001 doi: 10.1146/annurev-immunol-032713-120225 – ident: cit0014 doi: 10.1016/j.jid.2016.03.016 – ident: cit0007 doi: 10.1016/j.molcel.2018.11.018 – ident: cit0042 doi: 10.1038/ni.2215 – ident: cit0052 doi: 10.1186/s13024-018-0273-5 – ident: cit0003 doi: 10.1038/nri3532 – ident: cit0027 doi: 10.1182/blood-2002-12-3793 – ident: cit0028 doi: 10.4049/jimmunol.0902464 – ident: cit0072 doi: 10.1016/j.mam.2014.05.001 – ident: cit0063 doi: 10.1093/emboj/cdg516 – ident: cit0015 doi: 10.1242/jcs.144816 – ident: cit0019 doi: 10.1016/j.jid.2016.06.618 – ident: cit0016 doi: 10.1007/s00403-014-1508-0 – ident: cit0061 doi: 10.7150/thno.15584 – ident: cit0037 doi: 10.1038/emboj.2011.398 – ident: cit0013 doi: 10.18632/oncotarget.9330 – ident: cit0041 doi: 10.4161/viru.2.2.15480 – ident: cit0068 doi: 10.4049/jimmunol.1202495 – ident: cit0078 doi: 10.1084/jem.20100559 – ident: cit0054 doi: 10.1038/ncomms6779 – ident: cit0045 doi: 10.1007/s00403-013-1330-0 – ident: cit0004 doi: 10.1038/ni.3273 – ident: cit0017 doi: 10.1007/s00430-010-0163-0 – ident: cit0033 doi: 10.1016/j.immuni.2011.08.001 – ident: cit0079 doi: 10.1038/ncomms8687 – ident: cit0006 doi: 10.1038/cdd.2011.78 – ident: cit0059 doi: 10.1038/ncb2979 – ident: cit0021 doi: 10.1016/j.tcb.2012.04.008 – ident: cit0005 doi: 10.1080/15548627.2017.1402992 – ident: cit0044 doi: 10.1111/jdv.13564 – ident: cit0048 doi: 10.1146/annurev-immunol-020711-074948 – ident: cit0034 doi: 10.1172/JCI61862 – ident: cit0047 doi: 10.1002/path.4848 – start-page: 4:e11205 year: 2015 ident: cit0039 publication-title: eLife – ident: cit0075 doi: 10.1038/nprot.2009.241 – ident: cit0020 doi: 10.1016/j.bbadis.2018.02.003 – ident: cit0024 doi: 10.1080/15548627.2015.1100356 – ident: cit0026 doi: 10.4049/jimmunol.0802999 – ident: cit0018 doi: 10.4049/jimmunol.1001954 – ident: cit0022 doi: 10.1111/j.1365-2133.1992.tb07805.x – ident: cit0065 doi: 10.18632/oncotarget.17885 – ident: cit0049 doi: 10.1038/sj.cdd.4401984 – ident: cit0057 doi: 10.15252/embj.201695081 – ident: cit0046 doi: 10.1016/j.immuni.2009.08.001 – ident: cit0031 doi: 10.1016/j.cyto.2011.08.022 – ident: cit0067 doi: 10.1111/j.1346-8138.2011.01458.x – ident: cit0009 doi: 10.1016/S0140-6736(18)30485-9 – ident: cit0029 doi: 10.4049/jimmunol.1300047 – ident: cit0050 doi: 10.1016/j.bbrc.2014.11.038 – ident: cit0025 doi: 10.1038/jid.2012.318 – ident: cit0071 doi: 10.3389/fphys.2015.00093 – ident: cit0035 doi: 10.1007/s00018-011-0702-x – ident: cit0008 doi: 10.3389/fimmu.2018.01512 – ident: cit0002 doi: 10.1038/nri2622 – ident: cit0064 doi: 10.1038/onc.2012.631 – ident: cit0058 doi: 10.1016/j.molcel.2009.04.026 – ident: cit0011 doi: 10.2340/00015555-1183 – ident: cit0043 doi: 10.1038/nrrheum.2011.222 – ident: cit0012 doi: 10.1016/j.bcp.2016.06.001 – ident: cit0023 doi: 10.1038/emboj.2010.74 – ident: cit0060 doi: 10.1083/jcb.200911078 – ident: cit0076 doi: 10.1038/nprot.2008.50 – ident: cit0066 doi: 10.4049/jimmunol.1303297 – ident: cit0069 doi: 10.1146/annurev-immunol-030409-101323 – ident: cit0055 doi: 10.1016/j.immuni.2012.04.008  | 
    
| SSID | ssj0036892 | 
    
| Score | 2.6211925 | 
    
| Snippet | The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was... | 
    
| SourceID | unpaywall pubmedcentral proquest pubmed crossref informaworld  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 529 | 
    
| SubjectTerms | Alarmin autophagy keratinocytes psoriasis Research Paper secretion  | 
    
| Title | Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation | 
    
| URI | https://www.tandfonline.com/doi/abs/10.1080/15548627.2020.1725381 https://www.ncbi.nlm.nih.gov/pubmed/32019420 https://www.proquest.com/docview/2351519256 https://pubmed.ncbi.nlm.nih.gov/PMC8007160 https://www.tandfonline.com/doi/pdf/10.1080/15548627.2020.1725381?needAccess=true  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 17 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1554-8635 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0036892 issn: 1554-8635 databaseCode: DIK dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVLSH databaseName: aylor and Francis Online customDbUrl: mediaType: online eissn: 1554-8635 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036892 issn: 1554-8635 databaseCode: AHDZW dateStart: 20050401 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1554-8635 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0036892 issn: 1554-8635 databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAWR databaseName: Taylor & Francis Science and Technology Library-DRAA customDbUrl: eissn: 1554-8635 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036892 issn: 1554-8635 databaseCode: 30N dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.tandfonline.com/page/title-lists providerName: Taylor & Francis  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3bjtMwELV2u0Lwwv1SLisj8ZpuYjtO8oBQQSwV0lYgUWl5ihzHXqIWJ2oSVuGR7-Hf-AU8uZSWixYk3tKmU8WTsedMcnwGoSdMKFtYpcwhFgs7TCrmJKEWDqNcyzBQLmvbAZ3M-WzBXp_6p3vo7bAXBmiVUEPrTiiiXathchepHhhxR5ACLRAPbHVH7FcBsZPWe2bsaj9tmww-rda12kcH3LfwfIQOFvM30_etbqrPHDD8cUz9YVfPn_53J1_tqJn-DpP-Sq28XJtCNOditdrKW8fX0HoYcUdXWU7qKpnIzz-JQf5Xl1xHV3uUi6ddWN5Ae8rcRJe6vpfNLXQ-rUHPQJw1DmTRFNvkusV-xyVgWTjGucazk1fPPZw0eAn6z5nJZWPhMS5WoimxwEX2KbcFBAaaJM4MLsp8DeEmcbm0HzPz7esX8bHboHkbLY5fvnsxc_oOEI70KascX7lUA8uMaVsapiTiilI3TKhMReqKMAglCRPOuOYJD0gK0jjw3lZxTypKXHoHjUxu1D2EU8klCRRzk4gxV2gRhDplaSBoJBPqJ2PEhvscy14eHbp0rGKvV1EdfByDj-Pex2M02ZgVnT7IRQbRdhDFVftgRnddVGJ6ge3jIeJiuwrAqx1hVF6XMaEWl1qw7vMxuttF4OZyrB-8iBF3jIKd2Nz8ABTGd8-Y7EOrNB4CAuXW8mgTxX83yvv_bPEAXSFAF2oJ8Q_RCAL2kcV7VXKI9qk7P-zn8Xdr_Epe | 
    
| linkProvider | Unpaywall | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQESqX8oblaSSu2WZtx0mOBVEW6O6plXqLbMcu0S5J1GRbhSO_h__GX2Amj9UuDxWptySbidaTceab5PM3hLwRykJhlQqPARb2hLHC05FTnuDSmSi0vmjbAc3mcnoiPp0GpxtrYZBWiTW064Qi2mc1Tm58GT1Q4vYxBwISD6G8Y3AoZDBroQK6GQDYxy4G3J8PT2Muo7YxMpp4aDOs4vnXZbby05Z66d8w6J9Uyt1VXqrmUi2XG3nq8A4xwwg7espivKr12Hz7Tfzxei64S_Z6GEsPuri7R27Y_D651TW2bB6Qy4MVChaos8bDNJlSyJ4b9HZaIVjFbVo4Op19eDuhuqELFHjO8sI0gH9puVRNRRUts4sCKgSKPEia5bSsinOMJ0OrBexm-c8f39XXbgXmQ3Jy-P743dTrWzx4JuCi9gLrc4c0MuGg9ktZLC3nfqS5SVXqqyiMDIu0FNJJLUOWovYNfpi1cmIsZz5_RHbyIrdPCE2NNCy0wtexEL5yKoxcKtJQ8dhoHugREcONTUyvf45tOJbJpJdJHXyaoE-T3qcjMl6blZ0AyFUG8WbUJHX75sV1bVISfoXt6yHEEpjm-O1G5bZYVQnjADwBjQdyRB53Ibf-O-CHSSyYPyLhVjCuT0AJ8e1f8uxLKyUeIcSUYLm_Dtv_G-XTa4zyFdmdHs-OkqOP88_PyG2GLKGWB_-c7NTnK_sCYF6tX7bz-BdxV0QW | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JjtNAEG2hQSwX9iWsjcTVGae703aOwxLCMhEHRuJm9QpWgm2NbUbmyPfwb_wCVV6ihEWDNDfHTkXuSrXrlfv1K0KeCuWgsLIiYICFA2GcCHTsVSC49CaOXCjadkCHS7k4Em8-Tgc2YdnTKrGG9p1QRPusxsldWD8w4vYxBQIQj6C6Y3AqYjBpoQA6L3FVDHdxhMvhYcxl3PZFRpMAbYZNPP_6mZ30tCNe-jcI-ieT8lKdFao5Uev1VpqaXyV6GGDHTlmN60qPzbfftB_P5IFr5EoPYulBF3XXyTmX3SAXuraWzU1yclCjXIH61ASYJC2F3LlFbqclQlU8prmni8NXzyZUN3SF8s5plpsG0C8t1qopqaJF-jWH-oAiC5KmGS3K_BijydByBR_T7OeP7-pLt__yFjmav_zwfBH0DR4CM-WiCqYu5B5JZMJD5WfZTDrOw1hzY5UNVRzFhsVaCumllhGzqHyDy7JOTozjLOS3yV6WZ-4uodZIwyInQj0TIlReRbG3wkaKz4zmUz0iYvhfE9Orn2MTjnUy6UVSB58m6NOk9-mIjDdmRSf_cZrBbDtokqp97-K7JikJP8X2yRBhCUxyXLlRmcvrMmEQ2AC1AZ6OyJ0u4ja3A36YzAQLRyTaicXNF1BAfPdKln5uhcRjBJgSLPc3Uft_o7x3hlE-Jhffv5gn714v394nlxlShFoS_AOyVx3X7iFgvEo_amfxLzc3Qro | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3bjtMwELWWrhC8cL-Um4zEa7qJ7TjpA0IFsVRIuwKJSstT5PiyRC1O1CSswiPfw7_xC3hyKS0XLUi8pU2niidjz5nk-AxCT5jQrrBSzCMOC3tMaualsREeo9zIONI-a9sBHR3z-YK9PglP9tDbYS8M0CqhhjadUES7VsPkLpQZGHEHkAIdEI9cdUfcVxFxkzZ4Zt1qP2ubDD6t1rW-gPZ56OD5CO0vjt_M3re6qSHzwPDHMQ2HXT1_-t-dfLWjZvo7TPortfJSbQvRnInVaitvHV5F62HEHV1lOamrdCI__yQG-V9dcg1d6VEunnVheR3taXsDXez6XjY30dmsBj0Dcdp4kEUVdsl1i_2OS8CycIxzg-dHr54HOG3wEvSfM5vLxsFjXKxEU2KBi-xT7goIDDRJnFlclPkawk3icuk-Zvbb1y_iY7dB8xZaHL5892Lu9R0gPBlSVnmh9qkBlhkzrjRUZMo1pX6cUqmE8kUcxZLEKWfc8JRHRIE0Dry31TyQmhKf3kYjm1t9F2EluSSRZn46ZcwXRkSxUUxFgk5lSsN0jNhwnxPZy6NDl45VEvQqqoOPE_Bx0vt4jCYbs6LTBznPYLodREnVPpgxXReVhJ5j-3iIuMStAvBqR1id12VCqMOlDqyHfIzudBG4uRznh2DKiD9G0U5sbn4ACuO7Z2z2oVUajwGBcmd5sInivxvlvX-2uI8uE6ALtYT4B2gEAfvQ4b0qfdTP4O-0H0mM | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autophagy-based+unconventional+secretion+of+HMGB1+by+keratinocytes+plays+a+pivotal+role+in+psoriatic+skin+in%EF%AC%82ammation&rft.jtitle=Autophagy&rft.au=Wang%2C+Zhen&rft.au=Zhou%2C+Hong&rft.au=Zheng%2C+Huaping&rft.au=Zhou%2C+Xikun&rft.date=2021-02-01&rft.pub=Taylor+%26+Francis&rft.issn=1554-8627&rft.eissn=1554-8635&rft.volume=17&rft.issue=2&rft.spage=529&rft.epage=552&rft_id=info:doi/10.1080%2F15548627.2020.1725381&rft.externalDocID=1725381 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-8627&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-8627&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-8627&client=summon |